194 related articles for article (PubMed ID: 25261476)
21. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.
Goetz B; An W; Mohapatra B; Zutshi N; Iseka F; Storck MD; Meza J; Sheinin Y; Band V; Band H
Oncotarget; 2016 Aug; 7(32):51107-51123. PubMed ID: 27276677
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional analysis of CBLB mutations in type 1 diabetes.
Yokoi N; Fujiwara Y; Wang HY; Kitao M; Hayashi C; Someya T; Kanamori M; Oiso Y; Tajima N; Yamada Y; Seino Y; Ikegami H; Seino S
Biochem Biophys Res Commun; 2008 Mar; 368(1):37-42. PubMed ID: 18201552
[TBL] [Abstract][Full Text] [Related]
23. Ablation of Cbl-b provides protection against transplanted and spontaneous tumors.
Chiang JY; Jang IK; Hodes R; Gu H
J Clin Invest; 2007 Apr; 117(4):1029-36. PubMed ID: 17364027
[TBL] [Abstract][Full Text] [Related]
24. CBLB Constrains Inactivated Vaccine-Induced CD8
Nanjappa SG; Mudalagiriyappa S; Fites JS; Suresh M; Klein BS
J Immunol; 2018 Sep; 201(6):1717-1726. PubMed ID: 30054317
[TBL] [Abstract][Full Text] [Related]
25. Regulation of immune responses by E3 ubiquitin ligase Cbl-b.
Tang R; Langdon WY; Zhang J
Cell Immunol; 2019 Jun; 340():103878. PubMed ID: 30442330
[TBL] [Abstract][Full Text] [Related]
26. The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.
St Rose MC; Qui HZ; Bandyopadhyay S; Mihalyo MA; Hagymasi AT; Clark RB; Adler AJ
J Immunol; 2009 Oct; 183(8):4975-83. PubMed ID: 19801520
[TBL] [Abstract][Full Text] [Related]
27. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
28. Function of multiple sclerosis-protective HLA class I alleles revealed by genome-wide protein-quantitative trait loci mapping of interferon signalling.
Lundtoft C; Pucholt P; Imgenberg-Kreuz J; Carlsson-Almlöf J; Eloranta ML; Syvänen AC; Nordmark G; Sandling JK; Kockum I; Olsson T; Rönnblom L; Hagberg N
PLoS Genet; 2020 Oct; 16(10):e1009199. PubMed ID: 33104735
[TBL] [Abstract][Full Text] [Related]
29.
Song J; Anderson W; Hu A; Obata-Ninomiya K; Ziegler SF; Rawlings DJ; Buckner JH
J Immunol; 2022 Oct; 209(7):1260-1271. PubMed ID: 36165179
[TBL] [Abstract][Full Text] [Related]
30. Tumor rejection in
Schanz O; Cornez I; Yajnanarayana SP; David FS; Peer S; Gruber T; Krawitz P; Brossart P; Heine A; Landsberg J; Baier G; Wolf D
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34272310
[TBL] [Abstract][Full Text] [Related]
31. The CBLB gene and Graves' disease in children.
Chen CC; Huang CY; Huang FY; Dang CW; Lin CL; Lo FS; Lin CH; Tsang CC; Li HJ; Liu HF; Chu CC; Lin M; Lee YJ
J Pediatr Endocrinol Metab; 2005 Nov; 18(11):1119-26. PubMed ID: 16459459
[TBL] [Abstract][Full Text] [Related]
32. E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection.
Sharma J; Mudalagiriyappa S; Abdelaal HFM; Kelly TC; Choi W; Ponnuraj N; Vieson MD; Talaat AM; Nanjappa SG
J Leukoc Biol; 2024 May; 115(6):1118-1130. PubMed ID: 38271280
[TBL] [Abstract][Full Text] [Related]
33. Study of Cbl-b dynamics in peripheral blood lymphocytes isolated from patients with multiple sclerosis.
Zhou WB; Wang R; Deng YN; Ji XB; Huang GX; Xu YZ
Neurosci Lett; 2008 Aug; 440(3):336-9. PubMed ID: 18565657
[TBL] [Abstract][Full Text] [Related]
34. Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
Leikfoss IS; Keshari PK; Gustavsen MW; Bjølgerud A; Brorson IS; Celius EG; Spurkland A; Bos SD; Harbo HF; Berge T
PLoS One; 2015; 10(7):e0132957. PubMed ID: 26203907
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
[TBL] [Abstract][Full Text] [Related]
36. Cbl-b mediates TGFβ sensitivity by downregulating inhibitory SMAD7 in primary T cells.
Gruber T; Hinterleitner R; Hermann-Kleiter N; Meisel M; Kleiter I; Wang CM; Viola A; Pfeifhofer-Obermair C; Baier G
J Mol Cell Biol; 2013 Dec; 5(6):358-68. PubMed ID: 23709694
[TBL] [Abstract][Full Text] [Related]
37. Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.
Börnsen L; Romme Christensen J; Ratzer R; Hedegaard C; Søndergaard HB; Krakauer M; Hesse D; Nielsen CH; Sorensen PS; Sellebjerg F
PLoS One; 2015; 10(3):e0118830. PubMed ID: 25738751
[TBL] [Abstract][Full Text] [Related]
38. IFNγ Helps CBLB-Deficient CD8+ T Cells to Put Up Resistance to Tregs.
Wolf D; Baier G
Cancer Immunol Res; 2022 Apr; 10(4):370. PubMed ID: 35362047
[TBL] [Abstract][Full Text] [Related]
39. Relationship between Multiple Sclerosis-Associated
Buhelt S; Søndergaard HB; Oturai A; Ullum H; von Essen MR; Sellebjerg F
Cells; 2019 Jun; 8(6):. PubMed ID: 31242590
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of TYK2, CBLB and LMP7 genes expression in relapsing-remitting multiple sclerosis patients treated with interferon-beta.
Mazdeh M; Moradi N; Khoshroo E; Shayesteh Z; Taheri M; Sayad A; Omrani MD; Hajilooi M; Roshanaei G; Solgi G
J Neuroimmunol; 2018 Jan; 314():24-29. PubMed ID: 29157944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
